Mohammad Alhomoud
Overview
Explore the profile of Mohammad Alhomoud including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
27
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Luan D, DeWolf S, Fei T, Raj S, Shah G, Lareau C, et al.
Blood Cancer Discov
. 2024 Dec;
6(2):119-130.
PMID: 39666878
This study reveals differences in IR patterns after CAR-T therapy in patients with large B-cell lymphoma, with early NK cell recovery emerging as a key predictor of survival. These findings...
2.
Tix T, Alhomoud M, Shouval R, Cliff E, Perales M, Cordas Dos Santos D, et al.
Clin Cancer Res
. 2024 Sep;
30(20):4690-4700.
PMID: 39256908
Purpose: Chimeric antigen receptor (CAR) T-cell therapy is a potent immunotherapy for hematologic malignancies, but patients can develop long-term adverse events, including second primary malignancies (SPM) that impact morbidity and...
3.
Yamshon S, Gribbin C, Alhomoud M, Chokr N, Chen Z, Demetres M, et al.
Clin Lymphoma Myeloma Leuk
. 2024 Apr;
24(6):e235-e256.e2.
PMID: 38582666
Background: The application of CD19-directed chimeric antigen receptor T (CAR T) cell therapy has improved outcomes for thousands of patients with non-Hodgkin B cell lymphoma (NHL). The toxicities associated with...
4.
5.
Alhomoud M, Scordo M, Perales M
Bone Marrow Transplant
. 2024 Mar;
59(6):904-906.
PMID: 38467748
No abstract available.
6.
Alhomoud M, Magro C, Seshan S, Zhang T, Gomez-Arteaga A, Chokr N, et al.
Bone Marrow Transplant
. 2023 Aug;
58(11):1270-1274.
PMID: 37604872
No abstract available.
7.
Yamshon S, Gribbin C, Chen Z, Demetres M, Pasciolla M, Alhomoud M, et al.
Transplant Cell Ther
. 2023 Jun;
30(1):73.e1-73.e12.
PMID: 37279856
The safety and efficacy of chimeric antigen receptor (CAR) T cell therapy in solid organ transplant recipients is poorly understood, given the paucity of available data in this patient population....
8.
Sugita M, Yamazaki T, Alhomoud M, Martinet J, Latouche J, Golden E, et al.
Cell Death Dis
. 2023 May;
14(5):305.
PMID: 37142568
Autologous T cells engineered to express a chimeric antigen receptor (CAR) specific for CD19 are approved for the treatment of various CD19 hematological malignancies. While CAR T cells induce objective...
9.
Saldarriaga M, Alhomoud M, Roboz G, Allan J, Ruan J, Ouseph M, et al.
Am J Hematol
. 2023 Feb;
98(7):1119-1126.
PMID: 36785525
Peripheral blood smear (A) demonstrates increased numbers of plasma cells (representative cells indicated by arrows), (B) demonstrates polytypic nature of plasma cells.
10.
Alhomoud M, Soave R, Kluk M, Shore T
Am J Hematol
. 2023 Feb;
98(8):1341-1342.
PMID: 36746647
69-year-old man with a history of diffuse large B-cell lymphoma (DLBCL) presented with severe acute hemolytic anemia 27 months after an autologous hematopoietic stem cell transplantation. Bone marrow aspirate revealed...